Close monitoring is essential for detecting and managing unintended immune activation. Patients undergoing immunotherapy are regularly monitored through:
Blood tests to check for signs of inflammation and organ dysfunction Imaging studies to detect any inflammation in organs Clinical evaluations to assess symptoms and overall health status
